Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Spectral Medical Inc > Spectral Trading
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(125)
•••
Comment by Accountprinceon Jan 20, 2022 3:36pm
110 Views
Post# 34338980

RE:RE:Spectral Trading

RE:RE:Spectral TradingThanks MM.  You contribute more for the purpose of achieving shareholder value than the paid personnel and you'd be an awesome IR dept for good old EDT.  It has a lot going for it as we know but...shh...don't tell anyone.

Guess promoting the shares to achieve market value trading is not in the job description for Seto and co or for Bihl and co or for the various IR reps.  But please do show up to collect your cheques.  If we start to run short there's always another idiotically priced issue.

Broken promises?  How about the Investor Presentation on the website - "Coming Soon" - now removed from the website.  And no updated Investor Presentation to be seen anywhere.  Like Lucy holding the football and enticing all to run up and...nothing.  Guess this is bait and...nothing.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities